Article
National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.
Neuro-oncology - 6 Apr 2023
Ostrom Quinn T, Shoaf Madison L, Cioffi Gino, Waite Kristin, Kruchko Carol, Wen Patrick Y, Brat Daniel J, Barnholtz-Sloan Jill S, Iorgulescu J Bryan
Abstract excerpt
BACKGROUND: Molecularly-defined diffuse glioma types-including IDH-wildtype glioblastoma, IDH-mutant astrocytoma, IDH-mutant 1p/19q-codeleted oligodendroglioma, and H3 K27M-mutant diffuse midline glioma-were incorporated into U.S. cancer registry reporting for individuals with brain tumors beginning in 2018. We leveraged these new data to estimate the national-level overall survival (OS) patterns associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
